Search for a trial

1 results

Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate
the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with
Signs and Symptoms of Osteoarthritis of the Hip or Knee

Approved WMORecruitment stopped

The primary objective is to demonstrate the efficacy using 2 co-primary endpoints (as measured by thechanges from baseline to the end of Week 16 in Western Ontario and McMaster UniversityOsteoarthritis Index [WOMAC] pain and physical function…

Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee

Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate
the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with
Signs and Symptoms of Osteoarthritis of the Hip or Knee